Attached files
| file | filename |
|---|---|
| EX-23.2 - EX-23.2 - Centessa Pharmaceuticals plc | d123754dex232.htm |
| EX-23.1 - EX-23.1 - Centessa Pharmaceuticals plc | d123754dex231.htm |
| EX-5.1 - EX-5.1 - Centessa Pharmaceuticals plc | d123754dex51.htm |
| S-1MEF - S-1MEF - Centessa Pharmaceuticals plc | d123754ds1mef.htm |
Exhibit 23.3
CONSENT OF INDEPENDENT AUDITOR
We consent to the use in this Registration Statement on Form S-1 of Centessa Pharmaceuticals plc pursuant to Rule 462(b) of the Securities Act of 1933 of our reports dated March 12, 2021, relating to the financial statements of Palladio Biosciences, Inc.; Inexia Limited; Janpix Limited; Pega-One S.A.S.; PearlRiver Bio GmbH; Orexia Limited; Capella Bioscience Limited; and ApcinteX Limited, appearing in the Prospectus, which is part of this Registration Statement.
We also consent to the reference to us under the heading “Experts” in such Prospectus.
/s/ Frazier & Deeter, LLC
Tampa, Florida
May 27, 2021